Sequential Treatment Failure With Aztreonam-Ceftazidime-Avibactam Followed by Cefiderocol Due to Preexisting and Acquired Mechanisms in a New Delhi Metallo-β-lactamase–Producing Escherichia coli Causing Fatal Bloodstream Infection
Clinical Infectious Diseases · 14.06.2024 · 78 (6) · 1425-1428
DOI: 10.1093/cid/ciad759 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical Infectious Diseases, online erschienen am 30.01.2024. Verfasst von Fiona Senchyna und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Stanford University School of Medicine, Stanford, California, USA. Hauptthemen laut MEDLINE: Azabicyclo Compounds, beta-Lactamases, Aztreonam, Drug Combinations. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: Stanford Department of Pathology.
Abstract (Originalsprache)
We report a fatal case of New Delhi metallo-β-lactamase (NDM)–producing Escherichia coli in a bacteremic patient with sequential failure of aztreonam plus ceftazidime-avibactam followed by cefiderocol. Acquired resistance was documented phenotypically and mediated through preexisting and acquired mutations. This case highlights the need to rethink optimal treatment for NDM-producing organisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Stanford University School of Medicine, Stanford, California, USA.
- Clinical Microbiology Laboratory, Stanford University Medical Center,Palo Alto, California, USA.
- Division of Infectious Diseases, Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA.
- Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.
ORCID-Profile: Niaz Banaei
Förderung
- Stanford Department of Pathology
Zitieren
APA
Senchyna, F., Murugesan, K., Rotunno, W., Nadimpalli, S. S., Deresinski, S., & Banaei, N. (2024). Sequential Treatment Failure With Aztreonam-Ceftazidime-Avibactam Followed by Cefiderocol Due to Preexisting and Acquired Mechanisms in a New Delhi Metallo-β-lactamase–Producing Escherichia coli Causing Fatal Bloodstream Infection. Clinical Infectious Diseases, 78(6), 1425-1428. https://doi.org/10.1093/cid/ciad759
Vancouver
Senchyna F, Murugesan K, Rotunno W, Nadimpalli SS, Deresinski S, Banaei N. Sequential Treatment Failure With Aztreonam-Ceftazidime-Avibactam Followed by Cefiderocol Due to Preexisting and Acquired Mechanisms in a New Delhi Metallo-β-lactamase–Producing Escherichia coli Causing Fatal Bloodstream Infection. Clinical Infectious Diseases. 2024;78(6):1425-1428. doi:10.1093/cid/ciad759
BibTeX
@article{Senchyna2024,
author = {Senchyna, Fiona and Murugesan, Kanagavel and Rotunno, William and Nadimpalli, Sruti S and Deresinski, Stan and Banaei, Niaz},
title = {Sequential Treatment Failure With Aztreonam-Ceftazidime-Avibactam Followed by Cefiderocol Due to Preexisting and Acquired Mechanisms in a New Delhi Metallo-β-lactamase–Producing Escherichia coli Causing Fatal Bloodstream Infection},
journal = {Clinical Infectious Diseases},
year = {2024},
volume = {78},
number = {6},
pages = {1425--1428},
doi = {10.1093/cid/ciad759}
}
EUVIMED